Involvement of Transforming Growth Factor-β-Associated Kinase 1 in Fixed Airway Obstruction in Asthmatic Patients with Longer Disease Duration Independent on Airway Eosinophilia

References

• Bush A. Pathophysiological Mechanisms of Asthma. Front Pediatr. 2019;7:68. doi:10.3389/fped.2019.00068
   PubMed Web of Science ®Google Scholar
• Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled corticosteroid therapy in adult asthma. time for a new therapeutic dose terminology. Am J Respir Crit Care Med. 2019;199(12):1471–1477. doi:10.1164/rccm.201810-1868CI
   PubMed Web of Science ®Google Scholar
• Hsieh A, Assadinia N, Hackett TL. Airway remodeling heterogeneity in asthma and its relationship to disease outcomes. Front Physiol. 2023;14:1113100. doi:10.3389/fphys.2023.1113100
   PubMed Web of Science ®Google Scholar
• Poddighe D, Brambilla I, Licari A, Marseglia GL. Omalizumab in the therapy of pediatric asthma. Recent Pat Inflamm Allergy Drug Discov. 2018;12(2):103–109. doi:10.2174/1872213X12666180430161351
   PubMed Web of Science ®Google Scholar
• Fang L, Roth M. Airway wall remodeling in childhood asthma-a personalized perspective from cell type-specific biology. J Pers Med. 2021;11(11). doi:10.3390/jpm11111229
   Web of Science ®Google Scholar
• Hough KP, Curtiss ML, Blain TJ, et al. Airway remodeling in asthma. Front Med. 2020;7:191. doi:10.3389/fmed.2020.00191
   PubMed Web of Science ®Google Scholar
• James AL, Donovan GM, Green FHY, et al. Heterogeneity of airway smooth muscle remodeling in asthma. Am J Respir Crit Care Med. 2023;207(4):452–460. doi:10.1164/rccm.202111-2634OC
   PubMed Web of Science ®Google Scholar
• Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6):872–897. doi:10.1111/j.1365-2222.2008.02971.x
   PubMed Web of Science ®Google Scholar
• Osei ET, Mostaço-Guidolin L, Hsieh A, et al. Epithelial-interleukin-1 inhibits collagen formation by airway fibroblasts: implications for asthma. Sci Rep. 2020;10(1):8721. doi:10.1038/s41598-020-65567-z
   PubMed Web of Science ®Google Scholar
• Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77(4):1033–1079. doi:10.1152/physrev.1997.77.4.1033
   PubMed Web of Science ®Google Scholar
• Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet. 1989;1(8637):520–524. doi:10.1016/s0140-6736(89)90067-6
   PubMed Web of Science ®Google Scholar
• Chen YZ, Busse WW, Pedersen S, Tan W, Lamm CJ, O’Byrne PM. Early intervention of recent onset mild persistent asthma in children aged under 11 yrs: the steroid treatment as regular therapy in early asthma (START) trial. Pediatr Allergy Immunol. 2006;17(Suppl 17):7–13. doi:10.1111/j.1600-5562.2006.00379.x
   PubMedGoogle Scholar
• Castro-Rodriguez JA, Rodriguez-Martinez CE, Ducharme FM. Daily inhaled corticosteroids or montelukast for preschoolers with asthma or recurrent wheezing: a systematic review. Pediatr Pulmonol. 2018;53(12):1670–1677. doi:10.1002/ppul.24176
   PubMed Web of Science ®Google Scholar
• Broekema M, Timens W, Vonk JM, et al. Persisting remodeling and less airway wall eosinophil activation in complete remission of asthma. Am J Respir Crit Care Med. 2011;183(3):310–316. doi:10.1164/rccm.201003-0494OC
   PubMed Web of Science ®Google Scholar
• Halwani R, Al-Muhsen S, Al-Jahdali H, Hamid Q. Role of transforming growth factor-beta in airway remodeling in asthma. Am J Respir Cell Mol Biol. 2011;44(2):127–133. doi:10.1165/rcmb.2010-0027TR
   PubMed Web of Science ®Google Scholar
• Redington AE, Madden J, Frew AJ, et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997;156(2 Pt 1):642–647. doi:10.1164/ajrccm.156.2.9605065
   PubMed Web of Science ®Google Scholar
• Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003;112(7):1029–1036. doi:10.1172/JCI17974
   PubMed Web of Science ®Google Scholar
• Minshall EM, Leung DY, Martin RJ, et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1997;17(3):326–333. doi:10.1165/ajrcmb.17.3.2733
   PubMed Web of Science ®Google Scholar
• Moore B, Murphy RF, Agrawal DK. Interaction of tgf-beta with immune cells in airway disease. Curr Mol Med. 2008;8(5):427–436. doi:10.2174/156652408785160943
   PubMed Web of Science ®Google Scholar
• Aghasafari P, George U, Pidaparti R. A review of inflammatory mechanism in airway diseases. Inflamm Res. 2019;68(1):59–74. doi:10.1007/s00011-018-1191-2
   PubMed Web of Science ®Google Scholar
• Torrego A, Hew M, Oates T, Sukkar M, Fan Chung K. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax. 2007;62(4):307–313. doi:10.1136/thx.2006.063487
   PubMed Web of Science ®Google Scholar
• McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol. 2005;174(9):5774–5780. doi:10.4049/jimmunol.174.9.5774
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Hense G, Martin C, et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol. 2006;117(1):111–118. doi:10.1016/j.jaci.2005.09.017
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American thoracic society was adopted by the ATS board of directors, November 1986. Am Rev Respir Dis. 1987;136(1):225–244. doi:10.1164/ajrccm/136.1.225
   PubMed Web of Science ®Google Scholar
• Sekiya K, Taniguchi M, Fukutomi Y, et al. Persistent airflow obstruction in young adult asthma patients. Allergol Int. 2012;61(1):143–148. doi:10.2332/allergolint.11-OA-0331
   PubMed Web of Science ®Google Scholar
• Sexton P, Black P, Wu L, et al. Fixed airflow obstruction among nonsmokers with asthma: a case-comparison study. J Asthma. 2013;50(6):606–612. doi:10.3109/02770903.2013.793706
   PubMed Web of Science ®Google Scholar
• Kaminska M, Foley S, Maghni K, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol. 2009;124(1):45–51e1–4. doi:10.1016/j.jaci.2009.03.049
   Web of Science ®Google Scholar
• Quanjer PH, Brazzale DJ, Boros PW, Pretto JJ. Implications of adopting the global lungs initiative 2012 all-age reference equations for spirometry. Eur Respir J. 2013;42(4):1046–1054. doi:10.1183/09031936.00195512
   PubMed Web of Science ®Google Scholar
• Swanney MP, Ruppel G, Enright PL, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax. 2008;63(12):1046–1051. doi:10.1136/thx.2008.098483
   PubMed Web of Science ®Google Scholar
• Maneechotesuwan K, Ekjiratrakul W, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ. Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2,3-dioxygenase. J Allergy Clin Immunol. 2010;126(4):754–762e1. doi:10.1016/j.jaci.2010.08.005
   PubMed Web of Science ®Google Scholar
• Ito K, Jazrawi E, Cosio B, Barnes PJ, Adcock IM. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex. J Biol Chem. 2001;276(32):30208–30215. doi:10.1074/jbc.M103604200
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18(7):816–827. doi:10.1096/fj.03-1273rev
   PubMed Web of Science ®Google Scholar
• Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001;276(23):19945–19953. doi:10.1074/jbc.M102382200
   PubMed Web of Science ®Google Scholar
• Thompson K, Murphy-Marshman H, Leask A. ALK5 inhibition blocks TGFbeta-induced CCN1 expression in human foreskin fibroblasts. J Cell Commun Signal. 2014;8(1):59–63. doi:10.1007/s12079-014-0229-7
   PubMed Web of Science ®Google Scholar
• Landstrom M. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol. 2010;42(5):585–589. doi:10.1016/j.biocel.2009.12.023
   PubMed Web of Science ®Google Scholar
• Guo F, Hutchenreuther J, Carter DE, Leask A. TAK1 is required for dermal wound healing and homeostasis. J Invest Dermatol. 2013;133(6):1646–1654. doi:10.1038/jid.2013.28
   PubMed Web of Science ®Google Scholar
• Shi-wen X, Parapuram SK, Pala D, et al. Requirement of transforming growth factor beta-activated kinase 1 for transforming growth factor beta-induced alpha-smooth muscle actin expression and extracellular matrix contraction in fibroblasts. Arthritis Rheum. 2009;60(1):234–241. doi:10.1002/art.24223
   PubMedGoogle Scholar
• Joetham A, Schedel M, Ning F, Wang M, Takeda K, Gelfand EW. Dichotomous role of TGF-beta controls inducible regulatory T-cell fate in allergic airway disease through Smad3 and TGF-beta-activated kinase 1. J Allergy Clin Immunol. 2020;145(3):933–946e4. doi:10.1016/j.jaci.2019.09.032
   PubMed Web of Science ®Google Scholar
• Manuyakorn W, Kamchaisatian W, Atamasirikul K, Sasisakulporn C, Direkwattanachai C, Benjaponpitak S. Serum TGF-beta1 in atopic asthma. Asian Pac J Allergy Immunol. 2008;26(4):185–189.
   PubMed Web of Science ®Google Scholar
• Chu HW, Halliday JL, Martin RJ, Leung DY, Szefler SJ, Wenzel SE. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med. 1998;158(6):1936–1944. doi:10.1164/ajrccm.158.6.9712073
   PubMed Web of Science ®Google Scholar
• Joseph J, Benedict S, Badrinath P, et al. Elevation of plasma transforming growth factor beta1 levels in stable nonatopic asthma. Ann Allergy Asthma Immunol. 2003;91(5):472–476. doi:10.1016/S1081-1206(10)61516-5
   PubMed Web of Science ®Google Scholar
• Mo Y, Kim Y, Bang JY, et al. Mesenchymal stem cells attenuate asthmatic inflammation and airway remodeling by modulating macrophages/monocytes in the IL-13-overexpressing mouse model. Immune Netw. 2022;22(5):e40. doi:10.4110/in.2022.22.e40
   PubMed Web of Science ®Google Scholar
• Ogger PP, Albers GJ, Hewitt RJ, et al. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020;5(52). doi:10.1126/sciimmunol.abc1884
   PubMed Web of Science ®Google Scholar
• Tomita K, Tanigawa T, Yajima H, et al. Identification and characterization of monocyte subpopulations from patients with bronchial asthma. J Allergy Clin Immunol. 1995;96(2):230–238. doi:10.1016/s0091-6749(95)70012-9
   PubMed Web of Science ®Google Scholar
• Saradna A, Do DC, Kumar S, Fu QL, Gao P. Macrophage polarization and allergic asthma. Transl Res. 2018;191:1–14. doi:10.1016/j.trsl.2017.09.002
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Wakahara K, Nishio T, Ito S, Hasegawa Y. Airway basophils are increased and activated in eosinophilic asthma. Allergy. 2017;72(10):1532–1539. doi:10.1111/all.13197
   PubMed Web of Science ®Google Scholar
• Brooks CR, van Dalen CJ, Hermans IF, Gibson PG, Simpson JL, Douwes J. Sputum basophils are increased in eosinophilic asthma compared with non-eosinophilic asthma phenotypes. Allergy. 2017;72(10):1583–1586. doi:10.1111/all.13185
   PubMed Web of Science ®Google Scholar
• Boulet L-P. Airway remodeling in asthma. Curr Opin Pulm Med. 2018;24(1):56–62. doi:10.1097/mcp.0000000000000441
   PubMed Web of Science ®Google Scholar
• Sousa AW, Barros Cabral AL, Arruda Martins M, Carvalho CRF. Risk factors for fixed airflow obstruction in children and adolescents with asthma: 4-year follow-up. Pediatr Pulmonol. 2020;55(3):591–598. doi:10.1002/ppul.24625
   PubMed Web of Science ®Google Scholar
• Bennett GH, Carpenter L, Hao W, Song P, Steinberg J, Baptist AP. Risk factors and clinical outcomes associated with fixed airflow obstruction in older adults with asthma. Ann Allergy Asthma Immunol. 2018;120(2):164–168 e1. doi:10.1016/j.anai.2017.10.004
   PubMed Web of Science ®Google Scholar
• Lee JH, Haselkorn T, Borish L, Rasouliyan L, Chipps BE, Wenzel SE. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest. 2007;132(6):1882–1889. doi:10.1378/chest.07-0713
   PubMed Web of Science ®Google Scholar
• Schleich FN, Seidel L, Sele J, et al. Exhaled nitric oxide thresholds associated with a sputum eosinophil count >/=3% in a cohort of unselected patients with asthma. Thorax. 2010;65(12):1039–1044. doi:10.1136/thx.2009.124925
   PubMed Web of Science ®Google Scholar
• Volbeda F, Broekema M, Lodewijk ME, et al. Clinical control of asthma associates with measures of airway inflammation. Thorax. 2013;68(1):19–24. doi:10.1136/thoraxjnl-2012-201861
   PubMed Web of Science ®Google Scholar
• Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy. 2005;35(9):1175–1179. doi:10.1111/j.1365-2222.2005.02314.x
   PubMed Web of Science ®Google Scholar
• Gao J, Chen Z, Jie X, Ye R, Wu F. Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma. J Asthma Allergy. 2018;11:73–79. doi:10.2147/JAA.S155379
   PubMed Web of Science ®Google Scholar
• Crespo-Lessmann A, Curto E, Mateus Medina EF, et al. Characteristics of induced-sputum inflammatory phenotypes in adults with asthma: predictors of bronchial eosinophilia. J Asthma Allergy. 2023;16:95–103. doi:10.2147/JAA.S389402
   PubMed Web of Science ®Google Scholar
• Mogensen I, Alving K, Dahlen SE, et al. Fixed airflow obstruction relates to eosinophil activation in asthmatics. Clin Exp Allergy. 2019;49(2):155–162. doi:10.1111/cea.13302
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang X, Zhang L, et al. Age-related clinical characteristics, inflammatory features, phenotypes, and treatment response in asthma. J Allergy Clin Immunol Pract. 2023;11(1):210–219 e3. doi:10.1016/j.jaip.2022.09.029
   PubMed Web of Science ®Google Scholar
• Jang AS, Lee JH, Park SW, Park JS, Kim DJ, Park CS. Risk factors related to fixed airway obstruction in patients with asthma after antiasthma treatment. Ann Allergy Asthma Immunol. 2007;99(5):408–412. doi:10.1016/S1081-1206(10)60564-9
   PubMed Web of Science ®Google Scholar
• Jang AS, Park JS, Lee JH, et al. Asthmatics without rhinitis have more fixed airway obstruction than those with concurrent rhinitis. Allergy Asthma Immunol Res. 2010;2(2):108–113. doi:10.4168/aair.2010.2.2.108
   PubMed Web of Science ®Google Scholar
• Liu L, Liu Y, Zhang X, et al. Dyslipidemia is associated with worse asthma clinical outcomes: a prospective cohort study. J Allergy Clin Immunol Pract. 2022;2022:1. doi:10.1016/j.jaip.2022.11.037
   Google Scholar